Psychiatric Disorders: Clinical Trials

3 trials for Psychiatric Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn, 1 active not recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Withdrawn 2, Active not recruiting 1

Follow Psychiatric Disorders: new trials by email Literature Review of Psychiatric Disorders trials Research Report on Psychiatric Disorders

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
Semaglutide in combination with a healthy lifestyle intervention (diet and exercise) - Obesity and Obesity-related Medical Conditions, Psychiatric Disorders
Phase 4Active not recruitingSt Andrew's Healthcare202025-01-012026-04-28
Clinical Utility of Pharmacogenomics of Psychotropic Medications
Genetically-guided treatment with FDA-approved psychotropic drugs, Treatment as usual (TAU) - Psychiatric Disorders, Pain
Phase 4WithdrawnOregon Health and Science University2019-06-032023-09-21
Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
Varenicline, Nicotine patch - Tobacco Use Cessation, Psychiatric Disorders
Phase 4WithdrawnHospital Universitari Vall d'Hebron Research Institute2019-01-012019-03-12

Narrower conditions

Mental Disorders (3)  ·  Obesity (1)  ·  Pain (1)  ·  Tobacco Use Cessation (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Behavior (1)  ·  Body Weight (1)  ·  Health Behavior (1)  ·  Neurologic Manifestations (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)

Interventions

Diet (1)  ·  Exercise (1)  ·  Nicotine (1)  ·  Therapeutics (1)  ·  Tobacco Use Cessation Devices (1)  ·  Varenicline (1)  ·  semaglutide (1)

Sponsors

Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Oregon Health and Science University (1)  ·  St Andrew's Healthcare (1)

Countries

Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Cristina Pinet, MD (1)  ·  Dolores Braquehais, PhD (1)  ·  Eugeni Bruguera, MD (1)  ·  Gemma Nieva, PhD (1)  ·  Kieran C Breen, PhD (1)  ·  Mujeeb U Shad, MD, MSCS (1)

Results publications

PMID 41364787